Novel 1,2,3-thiadiazole derivatives as HIV-1 NNRTIs with improved potency: Synthesis and preliminary SAR studies

Peng Zhan; Xinyong Liu; Zhenyu Li; Zengjun Fang; Zhong Li; Defeng Wang; Christophe Pannecouque; De Clercq Erik

doi:10.1016/j.bmc.2009.07.004

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2013

Design, synthesis and preliminary SAR studies of novel N-arylmethyl substituted piperidine-linked aniline derivatives as potent HIV-1 NNRTIs

Lingzi Zhang, Peng Zhan, Xuwang Chen, Zhenyu Li, Zhoumeng Xie, Tong Zhao, Huiqing Liu, De Clercq Erik, Christophe Pannecouque, Jan Balzarini, Xinyong Liu

Article2013

Synthesis and biological evaluation of pyridazine derivatives as novel HIV-1 NNRTIs

Dongyue Li, Peng Zhan, Huiqing Liu, Christophe Pannecouque, Jan Balzarini, De Clercq Erik, Xinyong Liu

Article2017

Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives as potent HIV-1 NNRTIs

Zhaoqiang Liu, Ye Tian, Jinghan Liu, Boshi Huang, Dongwei Kang, De Clercq Erik, Dirk Daelemans, Christophe Pannecouque, Peng Zhan, Xinyong Liu

Preprint2024

Design and Synthesis of Novel Diarylpyrimidine Derivatives as Hiv-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Improved Potency and Metabolic Stability

Xinyong Liu, Hao Lin, Da Feng, Jie Guo, Xiangyi Jiang, Yanying Sun, Xiangkai Ji, De Clercq Erik, Christophe Pannecouque, Chin‐Ho Chen, Dongwei Kang, Peng Zhan

Article2021

Design, synthesis and anti-HIV evaluation of novel 5-substituted diarylpyrimidine derivatives as potent HIV-1 NNRTIs

Ping Gao, Shu Song, Zhao Wang, Lin Sun, Jian Zhang, Christophe Pannecouque, De Clercq Erik, Peng Zhan, Xinyong Liu